1. 1871 Inhibition of mTOR in combination with chemotherapy and angiogenic blockade shows activity in metaplastic breast cancer, an aggressive, chemo-refractory subtype of triple-negative breast cancer (TNBC). (September 2015) Authors: Basho, R.; Janku, F.; Helgason, T.; Gilcrease, M.; Booser, D.; Karp, D.; Meric-Bernstam, F.; Wheler, J.; Valero, V.; Albarracin, C.; Litton, J.; Chavez-MacGregor, M.; Ibrahim, N.; Murray, J.; Koenig, K.; Hong, D.; Subbiah, V.; Kurzrock, R.; Moulder, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2813 Comprehensive genomic profiling of clinically advanced medullary thyroid carcinoma. (September 2015) Authors: Heilmann, A.; Subbiah, V.; Wang, K.; Elvin, J.; Chmielecki, J.; Yelensky, R.; Vergilio, J.A.; Erlich, R.; Lipson, D.; Ross, J.; Miller, V.; Ali, S.; Stephens, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3007 Comprehensive genomic profiling characterizes the cpectrum of non-V600E activating BRAF alterations Including BRAF fusions in lung cancer. (September 2015) Authors: Ali, S.; Wang, K.; Johnson, A.; Suh, J.; Heilmann, A.; Lipson, D.; Yelensky, R.; Chmielecki, J.; Elvin, J.; Konduri, K.; Subbiah, V.; Stephens, P.; Ross, J.; Miller, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cancer-related internet use in patients with advanced cancer in a phase I clinical trials clinic. (December 2016) Authors: George, G.; Buford, A.; Hess, K.; Piha-Paul, S.; Zinner, R.; Subbiah, V.; Iwuanyanwu, E.; Cleeland, C.; Meric-Bernstam, F.; Bernstam, E.; Hong, D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Circulating Tumor DNA Dynamics Predict Outcomes of Systemic Therapy in Patients with Advanced Cancers. (October 2020) Authors: Gouda, M.; Huang, H.; Piha-Paul, S.; Call, S.G.; Karp, D.; Fu, S.; Naing, A.; Subbiah, V.; Pant, S.; Tsimberidou, A.M.; Hong, D.S.; Rodon, J.; Meric-Bernstam, F. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Differential Evolution Based IDWNN Controller for Fault Ride-Through of Grid-Connected Doubly Fed Induction Wind Generators. (1st October 2015) Authors: Manonmani, N.; Subbiah, V.; Sivakumar, L. Other Names: Sheela Gnana Academic Editor. Journal: TheScientificWorldjournal Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DNA Damage Response (DDR) Basket of Baskets (D-BOB) Trial: Phase 1/2 Study of the ATR inhibitor (ATRi) berzosertib and PD-L1 inhibitor avelumab in patients (pts) with advanced solid tumors with DDR molecular alterations. (October 2022) Authors: Ngoi, N.; Pilie, P.G.; Piha-Paul, S.A.; Dumbrava, E.E.; Fu, S.; Hong, D.S.; Karp, D.D.; Naing, A.; Pant, S.; Rodon Ahnert, J.; Subbiah, V.; Tsimberidou, A.M.; Salguero, C.; Brown, C.V.; Hoadley, W.E.; Johnson, A.; Yuan, Y.; Westin, S.N.; Meric-Bernstam, F.; Yap, T.A. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Drug development in the MD Anderson Cancer Center (MDACC) Clinical Translational Research Center (CTRC) – 2011–2015: The challenge of precision medicine in a very broad playing field. (December 2016) Authors: Dembla, V.; Ray, D.; Lockett, P.; Fullmer, C.; Subramanian, H.; Subbiah, V.; Fu, S.; Janku, F.; Tsimberidou, A.M.; Naing, A.; Piha-Paul, S.A.; Hong, D.S.; Pant, S.; Miller, V.A.; Lim, J.; Le, H.; Karp, D.D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor. (October 2022) Authors: Schram, A.; Borad, M.; Sahai, V.; Kamath, S.; Kim, R.; Liao, C.Y.A.; Oh, D.Y.; Ponz-Sarvisé, M.; Yachnin, J.; Shell, S.A.; Cassier, P.; Dotan, E.; Florou, V.; Moreno, V.; Park, J.O.; Tai, D.; Schmidt-Kittler, O.; Ferté, C.; Goyal, L.; Subbiah, V. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Incidence of immune-related adverse events in patients who received immunotherapy and radiographic analysis to predict pneumonitis. (December 2016) Authors: Fujii, T.; Colen, R.; Bilen, M.; Hess, K.; Hajjar, J.; Suarez-Almazor, M.; Alshawa, A.; Hong, D.; Stephen, B.; Janku, F.; Subbiah, V.; Kato, S.; Karp, D.; Piha-Paul, S.; Tsimberidou, A.; Fu, S.; Sharma, P.; Meric-Bernstam, F.; Naing, A. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗